EP 4192424 A1 20230614 - HYDROGEL COMPRISING GLYCEROL AND A CARBOMER FOR TREATING THE RESPIRATORY SYMPTOMS OF COVID-19 DISEASE VIA THE NASAL ROUTE
Title (en)
HYDROGEL COMPRISING GLYCEROL AND A CARBOMER FOR TREATING THE RESPIRATORY SYMPTOMS OF COVID-19 DISEASE VIA THE NASAL ROUTE
Title (de)
HYDROGEL MIT GLYCERIN UND EINEM CARBOMER ZUR BEHANDLUNG DER ATEMSYMPTOME DER COVID-19-KRANKHEIT ÜBER DIE NASE
Title (fr)
HYDROGEL COMPRENANT DU GLYCEROL ET UN CARBOMERE POUR LE TRAITEMENT PAR VOIE NASALE DES SYMPTOMES RESPIRATOIRES DE LA MALADIE COVID-19
Publication
Application
Priority
- FR 2008276 A 20200804
- FR 2010995 A 20201027
- EP 2021071696 W 20210803
Abstract (en)
[origin: WO2022029140A1] The invention relates to a product for treating viral diseases, such as COVID -19, via the nasal route. The product comprises a hydrogel based on water, glycerol and a carbomer.
IPC 8 full level
A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/047 (2006.01); A61K 31/78 (2006.01); A61K 47/10 (2017.01); A61K 47/32 (2006.01); A61K 47/36 (2006.01); A61K 47/46 (2006.01); A61P 11/02 (2006.01); A61P 31/02 (2006.01); A61P 31/14 (2006.01)
CPC (source: EP US)
A61K 9/0043 (2013.01 - EP US); A61K 9/06 (2013.01 - EP US); A61K 31/047 (2013.01 - EP); A61K 31/78 (2013.01 - EP); A61K 47/10 (2013.01 - EP US); A61K 47/32 (2013.01 - US); A61P 31/02 (2017.12 - EP); A61P 31/14 (2017.12 - EP US)
Citation (search report)
See references of WO 2022029140A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022029140 A1 20220210; CA 3188053 A1 20220210; CN 116249515 A 20230609; EP 4192424 A1 20230614; US 2023330013 A1 20231019
DOCDB simple family (application)
EP 2021071696 W 20210803; CA 3188053 A 20210803; CN 202180067905 A 20210803; EP 21755445 A 20210803; US 202118040468 A 20210803